Symbols / ORMP Stock $3.90 +1.30% Oramed Pharmaceuticals Inc.

Healthcare • Biotechnology • United States • NCM
ORMP (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
About

Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions with a technology platform for the oral delivery of therapeutic proteins. It develops ORMD-0801, an oral insulin capsule, which is in phase III clinical trial for the treatment of individuals with diabetes. The company has license agreements with Oravax Medical Inc. to commercialize oral vaccines for COVID-19 and other novel coronaviruses. Oramed Pharmaceuticals Inc. was incorporated in 2002 and is headquartered in New York, New York.

Stock Fundamentals
Scroll to Statements
Market Cap 157.74M Enterprise Value 32.67M Income 63.24M Sales 2.00M Book/sh 5.09 Cash/sh 3.11
Dividend Yield 6.39% Payout 0.00% Employees — IPO — P/E 2.60 Forward P/E -48.75
PEG — P/S 78.87 P/B 0.77 P/C — EV/EBITDA -2.18 EV/Sales 16.34
Quick Ratio 6.62 Current Ratio 6.98 Debt/Eq 0.41 LT Debt/Eq — EPS (ttm) 1.50 EPS next Y -0.08
EPS Growth — Revenue Growth — Earnings 2026-05-15 ROA -4.88% ROE 37.10% ROIC —
Gross Margin 0.65% Oper. Margin -7.54% Profit Margin 32.02% Shs Outstand 40.45M Shs Float 30.21M Short Float 1.65%
Short Ratio 4.47 Short Interest — 52W High 3.96 52W Low 1.98 Beta 1.25 Avg Volume 142.60K
Volume 97.96K Target Price $6.25 Recom None Prev Close $3.85 Price $3.90 Change 1.30%
Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$6.25
Mean price target
2. Current target
$3.90
Latest analyst target
3. DCF / Fair value
$1.74
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$3.90
Low
$6.25
High
$6.25
Mean
$6.25

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2024-09-09 reit HC Wainwright & Co. — → Neutral —
2024-05-20 reit HC Wainwright & Co. — → Neutral —
2023-05-17 main Canaccord Genuity Hold → Hold $2
2023-01-17 down HC Wainwright & Co. Buy → Neutral —
2023-01-12 down Canaccord Genuity Buy → Hold —
2022-05-16 main Aegis Capital — → Buy $30
2022-02-18 init Cantor Fitzgerald — → Overweight $20
2021-11-30 main HC Wainwright & Co. — → Buy $32
2021-11-29 main HC Wainwright & Co. — → Buy $32
2021-11-02 main Aegis Capital — → Buy $35
2021-07-29 main Canaccord Genuity — → Buy $30
2021-06-08 main Aegis Capital — → Buy $20
2021-04-20 init Canaccord Genuity — → Buy $27
2021-02-09 init National Securities Corporation — → Buy $23
2021-01-27 main Aegis Capital — → Buy $12
2020-07-13 reit HC Wainwright & Co. — → Buy $17
2020-06-22 main HC Wainwright & Co. — → Buy $16
2019-09-11 init Ladenburg Thalmann — → Buy $7
2015-11-19 init FBR Capital — → Outperform $15
2015-10-01 init HC Wainwright & Co. — → Buy $24
News
RSS: Latest ORMP news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-03-17 KIDRON NADAV Chief Executive Officer — 167,005 $0.00 $0
2026-03-17 KIDRON MIRIAM Officer and Director — 119,558 $0.00 $0
2026-03-17 HEXTER JOSHUA Chairman of the Board — 95,889 $0.00 $0
2026-03-17 GABAY AVRAHAM Chief Financial Officer — 95,889 $0.00 $0
2026-03-12 KIDRON NADAV Chief Executive Officer — 100,000 $0.00 $0
2026-01-22 KIDRON NADAV Chief Executive Officer — 109,000 — —
2026-01-22 KIDRON MIRIAM Officer and Director — 19,000 — —
2026-01-22 HEXTER JOSHUA Chief Operating Officer — 19,000 — —
2026-01-22 GABAY AVRAHAM Chief Financial Officer — 19,000 — —
2026-01-14 KIDRON MIRIAM Officer and Director — 86,166 $0.00 $0
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
2.00
0.00
-100.00%
1.34
-50.43%
2.70
Operating Revenue
2.00
0.00
-100.00%
1.34
-50.43%
2.70
Cost Of Revenue
1.99
0.00
—
—
Reconciled Cost Of Revenue
1.99
0.00
—
—
Gross Profit
0.01
0.00
—
—
Operating Expense
15.10
+18.15%
12.78
-25.30%
17.11
-60.49%
43.30
Research And Development
6.38
+0.90%
6.32
-29.51%
8.97
-67.54%
27.64
Selling General And Administration
8.72
+35.05%
6.46
-20.66%
8.14
-48.04%
15.66
Selling And Marketing Expense
—
0.00
+100.00%
-0.29
-115.51%
1.85
General And Administrative Expense
8.72
+35.05%
6.46
-23.36%
8.43
-39.00%
13.81
Other Gand A
8.72
+35.05%
6.46
-23.36%
8.43
-39.00%
13.81
Total Expenses
17.09
+33.70%
12.78
-25.30%
17.11
-60.49%
43.30
Operating Income
-15.09
-18.05%
-12.78
+18.95%
-15.77
+61.16%
-40.60
Total Operating Income As Reported
-15.09
-18.05%
-12.78
+18.95%
-15.77
+61.16%
-40.60
EBITDA
75.44
+607.23%
-14.87
-303.17%
7.32
+119.47%
-37.61
Normalized EBITDA
-12.24
-60.40%
-7.63
+14.70%
-8.95
+75.80%
-36.98
Reconciled Depreciation
0.12
-37.31%
0.19
-1.53%
0.20
+237.93%
0.06
EBIT
75.32
+599.93%
-15.07
-311.47%
7.12
+118.92%
-37.66
Total Unusual Items
87.69
+1310.81%
-7.24
-144.52%
16.27
+2682.22%
-0.63
Total Unusual Items Excluding Goodwill
87.69
+1310.81%
-7.24
-144.52%
16.27
+2682.22%
-0.63
Net Income
64.05
+436.04%
-19.06
-444.98%
5.53
+115.11%
-36.56
Pretax Income
75.32
+573.14%
-15.92
-412.89%
5.09
+113.51%
-37.66
Net Non Operating Interest Income Expense
1.77
-56.93%
4.10
-10.59%
4.59
+28.76%
3.56
Interest Expense Non Operating
0.00
-100.00%
0.85
-58.12%
2.04
0.00
Net Interest Income
1.77
-56.93%
4.10
-10.59%
4.59
+28.76%
3.56
Interest Expense
0.00
-100.00%
0.85
-58.12%
2.04
0.00
Interest Income Non Operating
2.37
-52.38%
4.98
-39.00%
8.17
+128.63%
3.57
Interest Income
2.37
-52.38%
4.98
-39.00%
8.17
+128.63%
3.57
Other Income Expense
88.64
+1324.04%
-7.24
-144.52%
16.27
+2682.22%
-0.63
Other Non Operating Income Expenses
0.96
—
—
—
Gain On Sale Of Security
87.69
+1310.81%
-7.24
-144.52%
16.27
+2682.22%
-0.63
Tax Provision
11.31
+255.26%
3.18
0.00
-100.00%
0.10
Tax Rate For Calcs
0.00
-28.51%
0.00
0.00
-100.00%
0.00
Tax Effect Of Unusual Items
13.16
+965.59%
-1.52
0.00
+100.00%
-0.13
Net Income Including Noncontrolling Interests
64.02
+435.11%
-19.10
-475.45%
5.09
+113.47%
-37.76
Net Income From Continuing Operation Net Minority Interest
64.05
+436.04%
-19.06
-444.98%
5.53
+115.11%
-36.56
Net Income From Continuing And Discontinued Operation
64.05
+436.04%
-19.06
-444.98%
5.53
+115.11%
-36.56
Net Income Continuous Operations
64.02
+435.11%
-19.10
-475.45%
5.09
+113.47%
-37.76
Minority Interests
0.03
-20.93%
0.04
-90.16%
0.44
-63.67%
1.20
Normalized Income
-10.47
+21.48%
-13.34
-24.16%
-10.74
+70.21%
-36.06
Net Income Common Stockholders
64.05
+436.04%
-19.06
-444.98%
5.53
+115.11%
-36.56
Diluted EPS
1.50
+412.50%
-0.48
-442.86%
0.14
+114.89%
-0.94
Basic EPS
1.53
+418.75%
-0.48
-442.86%
0.14
+114.89%
-0.94
Basic Average Shares
41.40
+1.35%
40.85
+1.33%
40.32
+3.38%
39.00
Diluted Average Shares
42.42
+3.84%
40.85
+0.70%
40.57
+4.02%
39.00
Diluted NI Availto Com Stockholders
64.05
+436.04%
-19.06
-444.98%
5.53
+115.11%
-36.56
Total Other Finance Cost
0.61
+2144.44%
0.03
-98.25%
1.54
+17044.44%
0.01
Line Item Trend 2023-12-31
Total Assets
220.55
Current Assets
162.58
Cash Cash Equivalents And Short Term Investments
162.05
Cash And Cash Equivalents
9.05
Cash Financial
9.05
Other Short Term Investments
152.99
Receivables
—
Prepaid Assets
—
Other Current Assets
0.54
Total Non Current Assets
57.97
Net PPE
1.57
Gross PPE
1.57
Machinery Furniture Equipment
—
Other Properties
1.57
Investments And Advances
54.93
Long Term Equity Investment
—
Other Investments
51.03
Non Current Prepaid Assets
0.01
Total Liabilities Net Minority Interest
57.66
Current Liabilities
53.21
Payables And Accrued Expenses
1.93
Payables
0.88
Accounts Payable
0.55
Dividends Payable
—
Current Accrued Expenses
1.06
Employee Benefits
0.03
Total Tax Payable
0.00
Income Tax Payable
0.00
Current Debt And Capital Lease Obligation
51.28
Current Debt
51.01
Current Capital Lease Obligation
0.27
Current Deferred Liabilities
0.00
Current Deferred Revenue
0.00
Total Non Current Liabilities Net Minority Interest
4.44
Long Term Debt And Capital Lease Obligation
0.34
Long Term Capital Lease Obligation
0.34
Defined Pension Benefit
0.03
Non Current Pension And Other Postretirement Benefit Plans
0.03
Tradeand Other Payables Non Current
—
Non Current Deferred Liabilities
4.01
Non Current Deferred Revenue
4.00
Non Current Deferred Taxes Liabilities
0.01
Other Non Current Liabilities
0.06
Stockholders Equity
163.82
Common Stock Equity
163.82
Capital Stock
0.48
Common Stock
0.48
Share Issued
40.34
Ordinary Shares Number
40.34
Treasury Shares Number
0.00
Additional Paid In Capital
320.89
Retained Earnings
-157.56
Minority Interest
-0.93
Total Equity Gross Minority Interest
162.89
Total Capitalization
163.82
Working Capital
109.37
Invested Capital
214.83
Total Debt
51.62
Net Debt
41.96
Capital Lease Obligations
0.61
Net Tangible Assets
163.82
Tangible Book Value
163.82
Available For Sale Securities
54.56
Dueto Related Parties Current
0.33
Financial Assets
1.44
Held To Maturity Securities
—
Investment Properties
—
Investmentin Financial Assets
54.93
Investmentsin Associatesat Cost
—
Line Of Credit
51.01
Non Current Note Receivables
—
Notes Receivable
—
Trading Securities
0.37
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
-9.14
-8.71%
-8.41
+18.29%
-10.29
+63.12%
-27.92
Cash Flow From Continuing Operating Activities
-9.14
-8.71%
-8.41
+18.29%
-10.29
+63.12%
-27.92
Net Income From Continuing Operations
64.02
+435.11%
-19.10
-475.45%
5.09
+113.47%
-37.76
Depreciation Amortization Depletion
0.12
-37.31%
0.19
-1.53%
0.20
+237.93%
0.06
Depreciation
0.12
-37.31%
0.19
-1.53%
0.20
+237.93%
0.06
Depreciation And Amortization
0.12
-37.31%
0.19
-1.53%
0.20
+237.93%
0.06
Other Non Cash Items
—
-1.46
-199.39%
1.47
+6590.91%
0.02
Pension And Employee Benefit Expense
-0.01
-140.00%
-0.01
-66.67%
-0.00
0.00
Stock Based Compensation
5.99
+47.84%
4.05
-3.77%
4.21
-63.40%
11.51
Deferred Tax
7.91
0.00
—
—
Deferred Income Tax
7.91
0.00
—
—
Operating Gains Losses
0.82
+130.24%
-2.71
-24.37%
-2.17
-39.16%
-1.56
Unrealized Gain Loss On Investment Securities
-86.10
-1261.42%
7.41
+145.22%
-16.39
-2248.36%
0.76
Net Foreign Currency Exchange Gain Loss
0.83
+130.74%
-2.70
-24.31%
-2.17
-40.13%
-1.55
Gain Loss On Sale Of PPE
—
—
0.00
+100.00%
-0.01
Change In Working Capital
-1.91
-159.59%
3.20
+218.69%
-2.70
-185.90%
-0.94
Change In Prepaid Assets
-1.00
-180.34%
-0.36
-141.78%
0.85
+217.91%
0.27
Change In Payables And Accrued Expense
1.13
-67.94%
3.52
+258.43%
-2.23
-491.76%
-0.38
Change In Payable
1.13
-67.94%
3.52
+258.43%
-2.23
-491.76%
-0.38
Change In Account Payable
1.13
-67.94%
3.52
+258.43%
-2.23
-491.76%
-0.38
Change In Other Working Capital
-1.98
-4497.78%
0.04
+103.40%
-1.32
-66.25%
-0.80
Change In Other Current Liabilities
-0.06
-328.57%
-0.01
-800.00%
0.00
+105.26%
-0.04
Investing Cash Flow
5.44
-94.86%
105.82
+244.88%
-73.04
-341.76%
30.21
Cash Flow From Continuing Investing Activities
5.44
-94.86%
105.82
+244.88%
-73.04
-341.76%
30.21
Net PPE Purchase And Sale
-1.93
-10638.89%
-0.02
+92.91%
-0.25
+46.19%
-0.47
Purchase Of PPE
-1.93
-10638.89%
-0.02
+92.91%
-0.25
+48.79%
-0.50
Sale Of PPE
—
—
0.00
-100.00%
0.02
Capital Expenditure
-1.93
-10638.89%
-0.02
+92.91%
-0.25
+48.79%
-0.50
Net Investment Purchase And Sale
8.38
-92.09%
105.90
+245.50%
-72.78
-337.23%
30.68
Purchase Of Investment
-88.51
-58.74%
-55.76
+70.80%
-190.92
-23.65%
-154.41
Sale Of Investment
96.88
-40.07%
161.66
+36.84%
118.14
-36.17%
185.09
Net Business Purchase And Sale
-7.25
0.00
—
—
Purchase Of Business
-7.25
0.00
—
—
Net Other Investing Changes
6.25
+9716.92%
-0.07
—
0.00
Financing Cash Flow
-4.74
+90.89%
-52.04
-200.11%
51.98
+382.22%
10.78
Cash Flow From Continuing Financing Activities
-4.74
+90.89%
-52.04
-200.11%
51.98
+382.22%
10.78
Net Issuance Payments Of Debt
0.00
+100.00%
-49.55
-200.00%
49.55
0.00
Issuance Of Debt
—
0.00
-100.00%
99.55
0.00
Repayment Of Debt
0.00
+100.00%
-49.55
+0.90%
-50.00
0.00
Long Term Debt Issuance
—
0.00
-100.00%
99.55
0.00
Long Term Debt Payments
—
—
-50.00
0.00
Net Long Term Debt Issuance
—
0.00
-100.00%
99.55
0.00
Short Term Debt Payments
0.00
+100.00%
-49.55
+0.90%
-50.00
0.00
Net Short Term Debt Issuance
0.00
+100.00%
-49.55
+0.90%
-50.00
0.00
Net Common Stock Issuance
-4.74
-90.86%
-2.48
-202.31%
2.43
-78.89%
11.50
Common Stock Payments
-4.74
-90.86%
-2.48
0.00
—
Repurchase Of Capital Stock
-4.74
-90.86%
-2.48
0.00
—
Proceeds From Stock Option Exercised
—
—
0.00
-100.00%
0.06
Net Other Financing Charges
—
-0.00
—
-0.78
Changes In Cash
-8.44
-118.61%
45.37
+244.69%
-31.36
-339.86%
13.07
Effect Of Exchange Rate Changes
-0.03
-650.00%
-0.00
+92.59%
-0.05
+15.63%
-0.06
Beginning Cash Position
54.42
+500.99%
9.05
-77.62%
40.46
+47.38%
27.46
End Cash Position
45.95
-15.57%
54.42
+500.99%
9.05
-77.62%
40.46
Free Cash Flow
-11.08
-31.41%
-8.43
+20.09%
-10.55
+62.87%
-28.41
Interest Paid Supplemental Data
0.00
-100.00%
2.32
+303.48%
0.57
0.00
Income Tax Paid Supplemental Data
—
—
0.00
-100.00%
0.10
Common Stock Issuance
—
0.00
-100.00%
2.43
-78.89%
11.50
Issuance Of Capital Stock
—
0.00
-100.00%
2.43
-78.89%
11.50
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category